Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28024819 | 0.98 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL16812082 | 0.96 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL3822855 | 0.87 | ALDH1A1 (0.34) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL28431642 | 0.84 | ALDH1A1 (0.32) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL6935674 | 0.83 | ALDH1A1 (0.38) | ALDH1A1LMNAGAAMEN1KMT2A | |
| SCHEMBL13742326 | 0.82 | GAA (0.40) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL12332050 | 0.82 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 | |
| SCHEMBL6935677 | 0.81 | KMT2A (0.34) | LMNAGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL12905043 | 0.81 | GAA (0.44) | GAAMEN1KMT2AL3MBTL1DGAT1 | |
| SCHEMBL12332048 | 0.80 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230141981-A1 | NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS | Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) | 2023-05-11 | — | — | US | disclosed |
| EP-3077460-B1 | SILICONE COMPOSITION THAT CAN BE CURED IN THE PRESENCE OF WATER OR ATMOSPHERIC MOISTURE | BLUESTAR SILICONES FRANCE (FR) | 2018-09-05 | — | — | EP | disclosed |
| EP-3077464-B1 | ARTICLE HAVING ANTIFOULING PROPERTIES, USED IN AQUATIC APPLICATIONS , IN PARTICULAR IN MARINE APPLICATIONS | BLUESTAR SILICONES FRANCE (FR) | 2018-01-31 | — | — | EP | disclosed |
| EP-3077464-A1 | ITEM HAVING ANTI-SOILING PROPERTIES AND INTENDED FOR AQUATIC AND PARTICULARLY OCEAN USE | Bluestar Silicones France SAS (FR) | 2016-10-12 | — | — | EP | disclosed |
| EP-3077460-A1 | SILICONE COMPOSITION THAT CAN BE CURED IN THE PRESENCE OF WATER OR ATMOSPHERIC MOISTURE | Bluestar Silicones France SAS (FR) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015082837-A1 | SILICONE COMPOSITION THAT CAN BE CURED IN THE PRESENCE OF WATER OR ATMOSPHERIC MOISTURE | BLUESTAR SILICONES FRANCE SAS (FR) | 2015-06-11 | — | — | WO | disclosed |
| WO-2015082780-A1 | ITEM HAVING ANTI-SOILING PROPERTIES AND INTENDED FOR AQUATIC AND PARTICULARLY OCEAN USE | BLUESTAR SILICONES FRANCE SAS (FR) | 2015-06-11 | — | — | WO | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| EP-2229395-A1 | SUBSTITUTED SULFONAMIDE DERIVATIVES | Grünenthal GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| WO-2009090054-A1 | SUBSTITUTED SULFONAMIDE DERIVATIVES | Grünenthal GmbH (DE) | 2009-07-23 | — | — | WO | disclosed |
| US-20070254247-A1 | Radiation-sensitive resin composition | YAMAMOTO MASAFUMI | 2007-11-01 | — | — | US | disclosed |
| EP-0548774-B1 | Process for producing a lactone or an ester | SUMITOMO CHEMICAL CO (JP) | 2000-03-15 | — | — | EP | disclosed |
| US-5405974-A | Reacting a ketone, oxygen, an aromatic aldehyde using an aromatic solvent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0548774-A1 | Process for producing a lactone or an ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | ALDH1A1 4072/4885LMNA 329/4885HSD17B10 3992/4885 |
| US-20230141981-A1 | NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS | GLS, ATP6V1B1, KRAS | ALDH1A1 1860/4885LMNA 2665/4885HSD17B10 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.